Literature DB >> 21521170

Mitochondria: the headquarters in ischemia-induced neuronal death.

Joaquin Jordan1, Piet W J de Groot, Maria F Galindo.   

Abstract

Due to a lack of efficient treatments, searching for novel therapies against acute ischemic stroke represents one of the main fields in neuropharmacology. In this review we summarize and discuss the role of mitochondrial participation in ischemia-induced neuronal death. Mitochondria are regarded as the main link between cellular stress signals and the execution of programmed death of nerve cells. Since it was described that the release of mitochondrial proteins such as cytochrome c, apoptosis inducing factor and endonuclease G are key elements in cell death pathways, they have been the focus of cell death studies. Changes in the permeability of the mitochondrial outer membrane result in a non-reversible step in cell death processes. Cytochrome c released from mitochondria binds in the cytoplasm to Apaf-1 to initiate the formation of an apoptosome, which then binds pro-caspase-9. Active caspase-9 cleaves "executioner" caspases, which in turn proceed to cleave key substrates in the cell. Thus, the identification of new targets might enable establishment of novel strategies for therapeutic research, in this case based on the molecular mechanisms of mitochondrial pathways, to improve the development of compounds for treatment of ischemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521170     DOI: 10.2174/187152411796011358

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  11 in total

Review 1.  Ischemic stroke and mitochondria: mechanisms and targets.

Authors:  Syed Suhail Andrabi; Suhel Parvez; Heena Tabassum
Journal:  Protoplasma       Date:  2019-10-14       Impact factor: 3.356

Review 2.  Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Authors:  A Grubman; A R White; J R Liddell
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm.

Authors:  Jakob Walther; Elena Marie Kirsch; Lina Hellwig; Sarah S Schmerbeck; Paul M Holloway; Alastair M Buchan; Philipp Mergenthaler
Journal:  Transl Stroke Res       Date:  2022-10-11       Impact factor: 6.800

Review 4.  Erythropoietin: powerful protection of ischemic and post-ischemic brain.

Authors:  Anh Q Nguyen; Brandon H Cherry; Gary F Scott; Myoung-Gwi Ryou; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04

5.  Tribulusterine Containing Tribulus terrestris Extract Exhibited Neuroprotection Through Attenuating Stress Kinases Mediated Inflammatory Mechanism: In Vitro and In Vivo Studies.

Authors:  R Ranjithkumar; Qasim Alhadidi; Zahoor A Shah; Muthiah Ramanathan
Journal:  Neurochem Res       Date:  2019-03-12       Impact factor: 3.996

6.  TDB protects vascular endothelial cells against oxygen-glucose deprivation/reperfusion-induced injury by targeting miR-34a to increase Bcl-2 expression.

Authors:  Li-Xi Liao; Ming-Bo Zhao; Xin Dong; Yong Jiang; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

7.  Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke.

Authors:  Syed Suhail Andrabi; Mubashshir Ali; Heena Tabassum; Sabiha Parveen; Suhel Parvez
Journal:  Dis Model Mech       Date:  2019-08-29       Impact factor: 5.758

8.  Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease.

Authors:  Maria F Galindo; Maria E Solesio; Sandra Atienzar-Aroca; Maria J Zamora; Joaquín Jordán Bueso
Journal:  Parkinsons Dis       Date:  2012-08-16

9.  Relaxin protects astrocytes from hypoxia in vitro.

Authors:  Jordan M Willcox; Alastair J S Summerlee
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Bone morphogenetic protein-7 ameliorates cerebral ischemia and reperfusion injury via inhibiting oxidative stress and neuronal apoptosis.

Authors:  Haitao Pei; Dongming Cao; Zhuangli Guo; Guofang Liu; Yunliang Guo; Chenglong Lu
Journal:  Int J Mol Sci       Date:  2013-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.